Skip to main content
. 2019 Jul 10;38(10):1259–1265. doi: 10.1097/ICO.0000000000001989

FIGURE 1.

FIGURE 1.

Patient disposition. Patients who received OTX-101 0.05% only in the phase 2b/3 study are not included in the present pooled analysis.